Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | CRO News | Industry News
Reaction Biology and 4HF Biotec Collaborate
Announce new cell-based service offering that combines their technologies.Contract Pharma Staff 10.21.20
-
Biologics, Proteins, Vaccines
India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines
CMOs expand and ‘repurpose’ capacities.Online Exclusives S Harachand, Contributing Editor 10.20.20
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Online Exclusives Kristin Brooks, Contract Pharma 10.20.20
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Breaking News | Clinical Trials | Collaborations & Alliances
Cytocom and Cleveland Biolabs Merge
Combine their businesses in an all-stock transaction.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Breaking News | Clinical Trials
Mereo Makes Leadership Changes
Appoints CFO and SVP, regulatory affairs.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement
Funding will be used for two Phase III trials and related development and manufacturing activities for the supply of AZD7442 doses in the U.S.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
The Discovery Labs Appoints President and COO
Taps former Lonza Exec, Jeorg Ahlgrimm.Contract Pharma Staff 10.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore
Investment supports global health and preparedness in the Asia-Pacific region.10.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Rentschler Biopharma and ATUM Ink Licensing Agreement
Leap-In Transposase technology will be integrated into Rentschler’s in-house process to complement existing CLD offering.Contract Pharma Staff 10.15.20
-
Clinical Trials | Information Technology
The Role of Electronic Monitoring in Maintaining Medication Adherence
Digital solutions offer hope to get patients to take their medications properly.Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20
-
Formulation Development
**ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production
A strong trend in drug substance and drug product biomanufacturing, as is for formulation, is that of increasing therapeutic complexity.Latika Bhonsle-Deeng, Rentschler Biopharma SE, and Konstantin Petropoulos, LEUKOCARE AG 10.14.20
-
Information Technology
You Need Solutions, Digitization is the Answer
Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20
-
Drug Delivery
Wet Wipes Increased Prevalence in Drug Development
A number of factors including patient preference are driving the growth of wet wipes in pharma.John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing 10.14.20
-
Drug Development | Drug Discovery | R&D
R&D Outsourcing Trends
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.Kristin Brooks, Managing Editor, Contract Pharma 10.14.20
